Catalent to Focus on European Expansion and New Drug Delivery Technologies at ICSE/CPhI Worldwide 2011

Catalent will highlight several new drug development and delivery options, including alliances with Sanwa Pharmaceuticals and Pantec AG for the global launch of OSDrC® OptiDose™ flexible modified release delivery, and Lyopan® fast-dissolve technology, respectively.

The pending addition of Aptuit's clinical trials supplies and pharmaceutical development and manufacturing operations will make Catalent a global leader in clinical trial solutions and further enhances its #1 position as a drug development and formulation partner globally.

On Tuesday, October 25, Catalent will host a Cocktail Reception on their stand (#40F04) from 1500-1600 hours to celebrate all their growth initiatives.

Additionally, Catalent experts will present on:

Monday, October 24, Will Downie, Senior Vice President of Global Sales & Marketing, will participate on the panel of CPhI's “Contract Partnership Executive Summit.” Panel discussions will center on the future of the pharma outsourcing industry. The panel will consider production costs, regulatory standards and convergence across international borders. More information on the summit may be found here.

Wednesday, October 26, Edwin Hoppenbrouwer, Catalent's Director of New Product Introduction, will present at the Speakers Corner of the Innopack exhibition on the subject of “Solving Tech Transfer Challenges for Complex Pharmaceutical Products."

On Wednesday evening, the nearby Frankfurt Marriott Hotel will play host to the 6th Anniversary of the European Outsourcing Awards. Catalent is a finalist in two categories for the “Most Effective Scale-Up/Tech Transfer” and “Outsourcing Executive of the Year.”

To schedule an interview with Catalent during CPhI Worldwide 2011, please contact Patricia McGee or Chris Halling . For more information on Catalent at ICSE, visit here.